A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients

Athanasios Tselebis, Dionisios Bratis, Argiro Pachi, Georgios Moussas, Ioannis Ilias, Maria Harikiopoulou, Elpida Theodorakopoulou, Silvia Dumitru, Epaminondas Kosmas, Alexandros Vgontzas, Nikolaos Siafakas, Nikolaos Tzanakis, Athanasios Tselebis, Dionisios Bratis, Argiro Pachi, Georgios Moussas, Ioannis Ilias, Maria Harikiopoulou, Elpida Theodorakopoulou, Silvia Dumitru, Epaminondas Kosmas, Alexandros Vgontzas, Nikolaos Siafakas, Nikolaos Tzanakis

Abstract

Background: The presence of anxiety and depressive symptoms in COPD patients has been acknowledged for many years. The preponderance of recent studies supports the utility of pulmonary rehabilitation programs to reduce the levels of depression and anxiety in these patients. The aim of this study is to investigate possible changes in levels of anxiety and depression among patients enrolled in a pulmonary rehabilitation program, along with the role of disease severity in these changes.

Methods: In 101 COPD patients, who attended a pulmonary rehabilitation program, levels of trait anxiety (STAI) and depressive symptoms (BDI) were assessed at the beginning and at the end of the program. Age, sex, level of education in years and stage of disease severity were recorded.

Results: Our study included 80 male and 21 female patients. Mean age and mean education level were 64.1 ± 8.1 and 11.3 ± 4.1 years, respectively. Regarding COPD staging, 11 patients suffered from mild, 16 from moderate, 47 from severe and 27 from very severe COPD. Significant decreases in anxiety (from 39.7 to 34.0, p < 0.001) and depression rates (from 10.7 to 6.3, p < 0.001) were observed. A statistically significant reduction in anxiety and depression was revealed (p < 0.05)at all stages of COPD.

Conclusion: Pulmonary rehabilitation programs should be offered to all COPD patients irrespective of disease severity, since they all lead to improvement in anxiety and depressive symptoms.

References

    1. Moussas G, Tselebis A, Karkanias A, Stamouli D, Ilias I, Bratis D, Vassila-Demi K. A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry. 2008;7:7. doi: 10.1186/1744-859X-7-7.
    1. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25:1209–1221. doi: 10.1002/gps.2463.
    1. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA. ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134 suppl:43S–56S.
    1. Wells KB, Golding J, Burnan MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1998;145:976–979.
    1. Tselebis A, Gournas G, Tzitzanidou G, Panagiotou A, Ilias I. Anxiety and depression in Greek nursing and medical personnel. Psychol Rep. 2006;99:93–96.
    1. Tselebis A, Bratis D, Kosmas E, Harikiopoulou M, Theodorakopoulou E, Dumitru S, Moussas G, Karkanias A, Ilias I, Siafakas N, Vgontzas A, Tzanakis N. Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease. Ann Gen Psychiatry. 2011;10:32. doi: 10.1186/1744-859X-10-32.
    1. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychosocial and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17:232–240.
    1. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355:362–368. doi: 10.1016/S0140-6736(99)07042-7.
    1. Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129:899–904. doi: 10.1378/chest.129.4.899.
    1. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(5 Suppl):4S–42S.
    1. Güell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129:899–904. doi: 10.1378/chest.129.4.899.
    1. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects ofpulmonary rehabilitation. J Cardiopulm Rehabil. 1999;19:362–365. doi: 10.1097/00008483-199911000-00007.
    1. Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest. 2003;124:94–97. doi: 10.1378/chest.124.1.94.
    1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) .
    1. Beck AT, Steer RA. Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corporation; 1987.
    1. Donias S, Demertzis I. In: Proceedings of the 10th Hellenic Congress of Neurology and Psychiatry: 1983. Varfis G, editor. Thessaloniki, Greece: University Studio Press; 1983. Validation of the Beck depression inventory; pp. 486–492.
    1. Tselebis A, Moulou A, Ilias I. Burnout versus depression and sense of coherence: A study in Greek nursing staff. Nurs Health Sci. 2001;3:69–71. doi: 10.1046/j.1442-2018.2001.00074.x.
    1. Spielberger GD, Gorush RL, Lusshene RE. The State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
    1. Liakos A, Giannitsi S. The validity of the Greek modification of the Spielberger anxiety scale. Encephalos. 1984;21:71–76.
    1. Tselebis A, Papaleftheris E, Balis E, Theotoka I, Ilias I. Smoking related to anxiety and depression in Greek medical staff. Psychol Rep. 2003;92:529–532. doi: 10.2466/pr0.2003.92.2.529.
    1. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767–1774. doi: 10.1016/j.rmed.2006.01.026.
    1. Voekel M, Voelkel NF, MacNee W. Chronic Obstructive Lung Diseases 2. Psychosocial aspects of Chronic Obstructive Pulmonary Disease. BC Decker Inc: City; 2008.
    1. Man GCW, Hsu K, Spoule BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest. 1986;90:832–836. doi: 10.1378/chest.90.6.832.
    1. Cantor L, Jacobson R. COPD: How to manage comorbid depression and anxiety. J Fam Pract. 2003;2:11.
    1. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58:65–70. doi: 10.1080/08039480310000824.
    1. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16:451–454. doi: 10.1002/gps.461.
    1. Eiser N, Harte R, Spiros K. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD. 2005;2:233–241. doi: 10.1081/COPD-57596.
    1. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry. 1995;152:1531.
    1. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998;39:24–29. doi: 10.1016/S0033-3182(98)71377-5.
    1. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61:140–147.
    1. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12:817–824. doi: 10.1002/(SICI)1099-1166(199708)12:8<817::AID-GPS645>;2-4.
    1. Silvertooth EJ, Doraiswamy PM, Clary GL, Babyak MA, Wilkerson N, Hellegars C, Palmer SM. Citalopram and quality of life in lung transplant recipients. Psychosomatics. 2004;45:271–272. doi: 10.1176/appi.psy.45.3.271.
    1. Yohannes AM, Connolly MJ. Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med. 2011;5(6):727–729. doi: 10.1586/ers.11.70.
    1. Post L, Collins C. The poorly coping COPD patient: a psychotherapeutic perspective. Int J Psychiatry Med. 1981–1982;11(2):173–182. doi: 10.2190/VUVV-2RQV-AG30-DPL1.
    1. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001;31:717–723.
    1. Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J. 1997;10:1581–1584. doi: 10.1183/09031936.97.10071581.
    1. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84:1154–1157. doi: 10.1016/S0003-9993(03)00239-9.
    1. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients; a randomized controlled trial. Psychol Med. 2008;38:385–396.
    1. Brook D. Exploring Group Therapies. Psychiatric Times. 2003. .
    1. Dishman RK. Brain monoamines, exercise, and behavioral stress: animal models. Med Sci Sports Exerc. 1997;29(1):63–74. doi: 10.1097/00005768-199701000-00010.
    1. Ransford CP. A role for amines in the antidepressant effect of exercise: a review. Med Sci Sports Exerc. 1982;14(1):1–10. doi: 10.1249/00005768-198201000-00001.
    1. Dunn AL, Reigle TG, Youngstedt SD, Armstrong RB, Dishman RK. Brain norepinephrine and metabolites after treadmill training and wheel running in rats. Med Sci Sports Exerc. 1996;28(2):204–209. doi: 10.1097/00005768-199602000-00008.
    1. Jacobs BL. Serotonin, motor activity and depression-related disorders. Am Sci. 1994;82:456–463.
    1. Chaouloff F. Effects of acute exercise on central serotonergic systems. Med Sci Sports Exerc. 1997;29(1):58–62. doi: 10.1097/00005768-199701000-00009.
    1. Raglin JS, Morgan WP. Influence of exercise and quiet rest on state anxiety and blood pressure. Med Sci Sports Exerc. 1981;19(5):456–463.
    1. Carr DB, Bullen BA, Skrinar GS, Arnold MA, Rosenblatt M, Beitins IZ, Martin JB, McArthur JW. Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med. 1981;305(10):560–563. doi: 10.1056/NEJM198109033051006.
    1. Farrell PA, Gates WK, Maksud MG, Morgan WP. Increases in plasma beta endorphin/beta-lipotropinimmunoreactivity after treadmillrunning in humans. J Appl Physiol. 1982;52(5):1245–1249.
    1. Gambert SR, Hagen TC, Garthwaite TL. Exercise and the endogenous opioids. N Engl J Med. 1981;305:1590–1591.
    1. Pitsavos C, Chrysohoou C, Panagiotakos DB, Skoumas J, Zeimbekis A, Kokkinos P, Stefanadis C, Toutouzas PK. Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study) Am J Cardiol. 2003;91(3):368–370. doi: 10.1016/S0002-9149(02)03175-2.
    1. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thomb Vasc Biol. 2002;22(11):1869–1876. doi: 10.1161/01.ATV.0000036611.77940.F8.
    1. Morrow J, Nolen-Hoeksema S. Effects of response to depression on the remediation of depressive affect. J Pers Soc Psychol. 1990;58(3):519–527.
    1. Nolen-Hoeksema S, Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta earthquake. J Pers Soc Psychol. 1991;61(1):115–121.
    1. McAuley E, Jerome GJ, Marquez DX, Elavsky S, Blissmer B. Exercise self-efficacy in older adults: social, affective, and behavioral influences. Ann Behav Med. 2003;25(1):1–7. doi: 10.1207/S15324796ABM2501_01.
    1. Craft LL. Exercise and clinical depression: examining two psychological mechanisms. Psychol Sport Exerc. 2003;6:151–171.
    1. Lewinsohn PM, Gotlib IH. In: Handbook of depression. 2. Beckham EE, Leber WR, editor. New York: Guildford Press; 1995. Behavioral theory and treatment of depression; pp. 352–375.
    1. Bartoholomew JB, Ciccolo JT. In: Exercise and its mediating effects on cognition. Spirduso WW, Poon LW, Chodzko-Zajko W, editor. Champaign, IL: Human Kinetcs; 2008. Exercise, depression, and cognition. 2.
    1. Tselebis A, Moussas G, Bratis D. Psychological intervention in a COPD rehabilitation programme [in Modern Greek] Pneumonologika Themata. 2006. pp. 21–23.
    1. Lacasse Y, Maltais F, Goldstein RS. Pulmonary rehabilitation: an integral part of the long-term management of COPD. Swiss Med Wkly. 2004;134(41–42):601–605.
    1. Paz-Dıaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2006;86(1):30–36.
    1. Pantou I, Harikiopoulou M, Bratis D, The impact of rehabilitation-induced symptomatic, functional and psychological outcomes on health-related quality of life. 2006. (European Respiratory Society, Annual Congress).
    1. Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, Hind D, Malpass A, Dickens C. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. 2013;8(4):e60532. doi: 10.1371/journal.pone.0060532.
    1. White RJ, Rudkin ST, Ashley J, Stevens VA, Burrows S, Pounsford JC, Cratchley G, Ambler NR. Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease. J R Coll Physicians Lond. 1997;31:541–545.
    1. Pantou I, Harikiopoulou M, Mpletsa M, Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation? 2007. (European Respiratory Society, Annual Congress).
    1. Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86(9):1788–1792. doi: 10.1016/j.apmr.2005.03.030.
    1. Edmunds M, Scudder L. Examining the Relationships Between COPD and Anxiety and Depression. Heart Lung. 2009;38:34–47. doi: 10.1016/j.hrtlng.2008.02.005.
    1. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–1211. doi: 10.1378/chest.127.4.1205.
    1. Hill K, Geist R, Goldstein RS. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667–677. doi: 10.1183/09031936.00125707.
    1. Tselebis A, Kosmas E, Bratis D, Moussas G, Karkanias A, Ilias I, Siafakas N, Vgontzas A, Tzanakis N. Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. Ann Gen Psychiatry. 2010;9:16. doi: 10.1186/1744-859X-9-16.
    1. Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Global assessment of the COPD patient: Time to look beyond FEV1? Respir Med. 2009;103:650–660. doi: 10.1016/j.rmed.2009.01.001.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera